Testing effectiveness (Phase 2)Study completedNCT00062114
What this trial is testing
Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 84